-+ 0.00%
-+ 0.00%
-+ 0.00%

Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate

Benzinga·09/02/2026 20:10:52
Listen to the news
Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(2.62) per share which missed the analyst consensus estimate of $(1.05) by 149.52 percent. The company reported quarterly sales of $1.918 million which missed the analyst consensus estimate of $3.113 million by 38.39 percent.